| Literature DB >> 34345361 |
Patrícia Helena Figueirêdo do Vale-Britto1, Laura Rabin2, Livia Spindola1, Ricardo Nitrini1, Sonia Maria Dozzi Brucki1.
Abstract
Judgment is the ability to make sound decisions after consideration of relevant information, possible solutions, likely outcomes, and contextual factors. Loss of judgment is common in patients with mild cognitive impairment (MCI) and dementia. The Test of Practical Judgment (TOP-J) evaluates practical judgment in adults and the elderly, with 15- and 9-item versions that require individuals to listen to scenarios about everyday problems and report their solutions.Entities:
Keywords: Alzheimer disease; frontotemporal dementia; judgment; mild cognitive impairment; neuropsychological tests
Year: 2021 PMID: 34345361 PMCID: PMC8283876 DOI: 10.1590/1980-57642021dn15-020007
Source DB: PubMed Journal: Dement Neuropsychol ISSN: 1980-5764
Summary of TOP-J data.
| Published studies | Sample | Test | Results |
|---|---|---|---|
| Rabin et al. | n=134: 14 AD, 34 amnestic MCI (aMCI), 39 with normal cognition but significant cognitive complaints (CC), and 35 controls (HC) | TOP-J/9 | HCs obtained higher scores than CC, MCI, and AD, while ADs obtained lower scores than HC, CC, and MCI participants (approximately 2 |
| Rabin et al. | n=120 (13 AD, 34 aMCI, 34 CC and 39 HC) | TOP-J/9 | Investigated the relationship between gray matter density and judgment controlling for age, education, gender, intracranial volume, verbal memory, and crystallized knowledge. Lower TOP-J scores were associated with reduced gray matter density in prefrontal regions (left inferior and superior frontal gyri). |
| Selected abstracts | |||
| Rabin et al. | n=210 (43 MCI, 62 CC, 105 HC) | TOP-J/15 | Re-evaluated validity of the TOP-J in a sample of older adults with different demographic characteristics than the original normative sample. HCs obtained higher TOP-J scores than MCI (CC and MCI did not differ). A notable finding was the 2- to 3-point (approximately 0.5 SD) reduction in scores among HC and MCI in the current (urban) as compared to the original (rural) sample. |
| Baldock et al. | n=18 (9 AD and 9 FTD) | Results revealed a statistically significant difference in performance between AD and FTD patients, matched on the basis of overall MoCA scores. | |
aMCI: amnestic MCI; MoCA: Montreal Cognitive Assessment; SD: standard deviation.
Sociodemographic profile and TOP-J/Br results
| Gender (n=85) | Age | Education | TOP-J/9 | TOP-J/15 | ||||
|---|---|---|---|---|---|---|---|---|
| Male | Female | Mean(SD) | Median | Mean(SD) | Median | Mean(SD) | Mean(SD) | |
| Controls | 8 | 16 | 65.5 (7.5) | 65 | 12.3(3.05) | 13 | 20.2 (2.4)A,B,C | 33.4 (4.0)A,B,C |
| MCI | 10 | 16 | 71.6(5.52) | 72 | 10.4(6.51) | 9 | 17.7 (3.5)A,D,E | 30.15 (4.88)A,D,E |
| AD | 9 | 11 | 75.1(6.24) | 77 | 9.3 (5.19) | 8 | 14.8 (4)B,D | 26.5 (4.9)B,D |
| FTDbv | 12 | 3 | 65.3(8.68) | 67 | 10.3(6.08) | 8 | 13.3 (4.9)C,E | 24.2 (6.47)C,E |
*Kruskal-Wallis test followed by Bonferroni test. AControl≠MCI; BControl≠AD; CControl≠FTD; DMCI≠AD; EMCI≠FTD.
Exploratory factor analysis to a single factor.
| Item | Domain | Factor loadings of TOP-J/15-Br | Factor loadings of TOP-J/9-Br | Factor loadings of original TOP-J/9 |
|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| TOP-J 3* | Safety* | 0.23* | n/a* | 1.10 |
|
|
|
|
|
|
| TOP-J 5* | Social/ethical* | 0.39* | n/a* | n/a |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TOP-J 9* | Safety* | 0.38* | n/a* | n/a |
| TOP-J 10 | Social/ethical | 0.50 | 0.54 | n/a |
| TOP-J 11* | Safety* | 0.34* | n/a* | n/a |
|
|
|
|
|
|
| TOP-J 13* | Medical* | 0.15* | n/a* | n/a |
| TOP-J 14 | Social/ethical | 0.53 | 0.58 | n/a |
| TOP-J 15* | Financial* | 0.33* | n/a* | 0.49 |
*Items not included in TOP-J /9-Br; Items in bold are common to the TOP-J/9 original and TOP-J/9-Br; The items are numbered according to their position on the TOP-J/15 protocol.
Cutoffs for TOP-J/Br.
| Group | Area under curve | Cutoff | Sensitivity % | Specificity % |
|---|---|---|---|---|
| Control versus MCI | 0.73** | 19 | 79.2 | 57.7 |
| Control versus AD | 0.87* | 18 | 83.3 | 70.0 |
| Control versus FTD | 0.90* | 18 | 83.3 | 73.3 |
| Control versus dementia | 0.89* | 18 | 83.3 | 71.4 |
| Control versus patient | 0.82* | 19 | 79.2 | 72.1 |
*p<0.001; **p<0.05.